Home
© 2026 Oncura All rights reserved.
Unison's oncology portfolio focuses on widely used, high-impact molecules for solid tumors and hematological malignancies and Supportive care range.
Hormonal therapies and targeted oral agents designed for long-term management with minimal toxicity.
Beyond treating cancer, we provide supportive medicines for nausea, skin care, and hair care—delivering true Care Beyond Treatment.
High-efficacy Pegylated liposomal generics for ovarian cancer.
Treatments for chronic leukemias and lymphomas.
Hormonal Depot & Supportive care.
Our portfolio is strategically built around four high-stakes categories where pharmaceutical precision and specialized handling are paramount.
Systemic cancer treatments often manifest as severe dermatological challenges. Oncura specializes in managing the skin-related toxicities that arise from radiation and chemotherapy, ensuring that the "care" extends to the patient's physical comfort and dignity.
Advanced agents designed to treat radiation-induced dermatitis and Hand-Foot Syndrome.
Specialized formulations to manage chemo-induced skin toxicities and rashes.
Protecting the skin barrier to prevent treatment interruptions and maintain patient well-being.
In the fight against hormone-sensitive cancers, modulation is a primary defense. Oncura provides essential hormonal therapies designed to inhibit tumor growth in endocrine-responsive malignancies.
Leading antiestrogens and aromatase inhibitors for the management of ER+ tumors.
Advanced androgen deprivation therapies (ADT) and LHRH agonists.
Long-term maintenance therapies that focus on disease suppression with minimal systemic impact.
As the backbone of most cancer protocols, cytotoxic drugs require the highest level of safety and supply-chain stability. Oncura ensures these high-potency agents are handled with rigorous precision.
A comprehensive range of alkylating agents and antimetabolites for solid and hematological tumors.
We utilize strictly monitored 2°C to 8°C logistics to ensure that high-sensitivity cytotoxics remain stable from the lab to the clinic.
We advocate for safe handling protocols to protect healthcare professionals from exposure during preparation and administration.
Biologics represent the frontier of modern oncology. Oncura specializes in large-molecule therapies that reprogram the body's own immune response to cancer.
Precision-targeted proteins that identify and neutralize specific cancer cell markers.
Cutting-edge immunotherapies that empower the patient's immune system to recognize and fight the disease.
Expanding access to life-saving biological therapies through high-quality, clinically validated biosimilars
Contact
Subscribe our News Letter
